# FDA Inspection 1263010 - Lady - February 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/lady/4db10bff-524c-4cd7-b4cb-073b06c865fc
Source feed: FDA_Inspections

> FDA Inspection 1263010 for Lady on February 14, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1263010
- Company Name: Lady
- Inspection Date: 2025-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1314970 - 2026-04-27](https://www.keypedia.com/records/fda_inspections/lady/c89cc2ab-cb9b-4e95-a679-3f7a16202294)
- [FDA Inspection 1288176 - 2025-10-22](https://www.keypedia.com/records/fda_inspections/lady/98731a3f-2c9f-448a-a60f-e2fbf3dc7a2a)
- [FDA Inspection 698886 - 2010-11-04](https://www.keypedia.com/records/fda_inspections/lady/b1eaf001-8f1d-4258-bffb-4808a9b9591d)
- [FDA Inspection 672041 - 2010-07-08](https://www.keypedia.com/records/fda_inspections/lady/792ef219-adef-413f-9fb1-84ebe526df07)

Company: https://www.keypedia.com/companies/lady/543827ab-a3d8-48f9-8fbf-b7c0f6221f3b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
